CFD
MIRM icon

Creative Financial Designs’s Mirum Pharmaceuticals MIRM Stock Holding History

Creative Financial Designs’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29K Sell
11
-2
-15% -$201 ﹤0.01% 1980
2026
Q1 		$1.2K Buy
13
+2
+18% +$188 ﹤0.01% 1862
2025
Q4 		$869 Hold
11
– – ﹤0.01% 1822
2025
Q3 		$806 Buy
+11
New +$699 ﹤0.01% 1840

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Creative Financial Designs's MIRM Position: Q2 2026 in Review

Creative Financial Designs reduced its Mirum Pharmaceuticals (MIRM) stake by 15% in Q2 2026, selling an estimated $201 and leaving 11 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

Creative Financial Designs first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Creative Financial Designs held 11 shares of Mirum Pharmaceuticals worth $1.29K as of Q2 2026.
  • Creative Financial Designs sold 2 Mirum Pharmaceuticals shares in Q2 2026, an estimated $201.
  • Mirum Pharmaceuticals made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1980 holding.
  • Creative Financial Designs first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.